|

Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

RECRUITINGSponsored by Third Affiliated Hospital, Sun Yat-Sen University
Actively Recruiting
SponsorThird Affiliated Hospital, Sun Yat-Sen University
Started2019-01-01
Est. completion2026-01-01
Eligibility
Age3 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06081231

Summary

This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.

Eligibility

Age: 3 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

1. diagnosed T1DM.
2. Currently use open-source APS for at least 3 months.
3. Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.
4. reside in China.

Exclusion Criteria:

None

Conditions2

DiabetesType 1 Diabetes Mellitus

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.